AGIC Capital (“AGIC”), a growth-oriented European-Asian private equity firm with $2.2 billion of assets under management has completed the investment of an undisclosed amount into AP Technologies (“AP Tech”), an…
DermaSensor Inc., a health technology company equipping primary care physicians (PCPs) with a non-invasive device for evaluating suspicious skin lesions, presented today promising results from a sub-analysis of the DERM-SUCCESS…
Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers in Hawaii that the Henry Schein Customer Assistance Hotline is open for dentists and physicians who may experience operational, logistical, or financial…
McKesson Medical-Surgical, an affiliate of the McKesson Corporation, will participate as a silver sponsor of the National Association of Community Health Centers National Health Center Week 2023 (NHCW) Aug. 6-12.…
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the…
Owens & Minor, Inc. (NYSE: OMI)today reported financial results for the second quarter ended June 30, 2023. Second Quarter Key Highlights: “The second quarter of 2023 shows a continuation of…
MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, is celebrating the one-year anniversary of the company’s FRED™ X Flow Diverter. In close collaboration with physician…
The global medical tubing market size is anticipated to reach USD 19,498.5 million by 2030. The market is expected to expand at a CAGR of 6.0% from 2023 to 2030…
The global transcatheter heart valve market is estimated to witness substantial growth, reaching a projected value of US$ 15.14 Billion by 2030 at a robust compound annual growth rate (CAGR)…
The global aneurysm clips market size is anticipated to reach USD 112.92 million by 2030, expanding at a CAGR of 7.36% from 2023 to 2030. The market is expected to…
The Global Gene Panel Market to 2028 report has been added to ResearchAndMarkets.com’s offering. The global gene panel market is poised for impressive growth during the forecast period, driven by the increasing prevalence of…
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced the completion of enrollment to the randomized, double-blind phase III ALTAIR clinical trial (JapicCTI-205363/NCT04457297). ALTAIR is the circulating…